久操视频网站,又大又粗又黄又刺激的免费视频,亚洲三级电影在线播放,国产亚洲视频在线观看二区

中文
中文

以患者需求為核心,驅(qū)動(dòng)細(xì)胞免疫治療創(chuàng)新,實(shí)現(xiàn)癌癥可控化并最終治愈。

We strive to make patients-driven cellular immunotherapy innovation, to transform cancer into a manageable condition — and ultimately cure it.

2022
  • 0
Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy. 
Cancer Cell 40, 674-693, June 13, 2022    doi:https://doi.org/10.1016/j.ccell.2022.04.018

Haixia Long, Qingzhu Jia, Liuyang Wang, Wenfeng Fang, Zhongyu Wang, Tao Jiang, Fei Zhou, Zheng Jin, Jiani Huang, Li Zhou, Chunyan Hu, Xinxin Wang, Jin Zhang, Yujie Ba, Yujie Gong, Xianghua Zeng, Dong Zeng, Xingxing Su, Peter B. Alexander, Li Wang, Limei Wang, Yisong Y. Wan, Xiao-Fan Wang, Li Zhang, Qi-Jing Li, Bo Zhu ( 2022)   

Breaking boundaries: current progress of anticancer NK cell-based drug development
Drug Discovery Today, PII: S1359-6446(22)00429-9 doi: https://doi.org/10.1016/j.drudis.2022.103436
Reference: DRUDIS 103436
Shuhang Wang, Kun Chen, Yale Jiang, Guo Zhao, Caie Wang, Hong Fang, Qiyu Tang, Chao Sun, Liang Zhang, Haiyang Wu, Li-Feng Zhang, Ning Li 

 
  • 上一篇:--
  • 下一篇:2021
06.14
2022
來(lái)源:
關(guān)鍵詞:
相關(guān)閱讀

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號(hào)

粵ICP備20056630號(hào) Powered by vancheer

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號(hào)

粵ICP備20056630號(hào) Powered by vancheer